These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 32048170)
41. The efficacy of topical cyproterone acetate alcohol lotion versus placebo in the treatment of the mild to moderate acne vulgaris: a double blind study. Iraji F; Momeni A; Naji SM; Siadat AH Dermatol Online J; 2006 Mar; 12(3):26. PubMed ID: 16638440 [TBL] [Abstract][Full Text] [Related]
42. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial. Plewig G; Cunliffe WJ; Binder N; Höschen K Contraception; 2009 Jul; 80(1):25-33. PubMed ID: 19501212 [TBL] [Abstract][Full Text] [Related]
43. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study. Enshaieh S; Jooya A; Siadat AH; Iraji F Indian J Dermatol Venereol Leprol; 2007; 73(1):22-5. PubMed ID: 17314442 [TBL] [Abstract][Full Text] [Related]
44. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial. Yao DN; Lu CJ; Wen ZH; Yan YH; Xuan ML; Li XY; Li G; He ZH; Xie XL; Deng JW; Guo XF; Ou AH Trials; 2016 Mar; 17(1):140. PubMed ID: 26983642 [TBL] [Abstract][Full Text] [Related]
45. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population. Han G; Armstrong AW; Desai SR; Guenin E J Drugs Dermatol; 2019 Sep; 18(9):910-916. PubMed ID: 31524347 [TBL] [Abstract][Full Text] [Related]
46. Anti-inflammatory effect of Keigai-rengyo-to extract and acupuncture in male patients with acne vulgaris: a randomized controlled pilot trial. Kim KS; Kim YB J Altern Complement Med; 2012 May; 18(5):501-8. PubMed ID: 22594649 [TBL] [Abstract][Full Text] [Related]
47. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population. Kircik LH; Baldwin H; Lain E; Guenin E; Harris S; Bhatt V J Drugs Dermatol; 2019 Feb; 18(2):178-188. PubMed ID: 30811141 [TBL] [Abstract][Full Text] [Related]
48. Acne RA-1,2, a novel UV-selective face cream for patients with acne: Efficacy and tolerability results of a randomized, placebo-controlled clinical study. Cestone E; Michelotti A; Zanoletti V; Zanardi A; Mantegazza R; Dossena M J Cosmet Dermatol; 2017 Jun; 16(2):265-270. PubMed ID: 28133878 [TBL] [Abstract][Full Text] [Related]
49. Chinese Medicine Sequential Therapy Improves Pregnancy Outcomes after Surgery for Endometriosis-Associated Infertility: A Multicenter Randomized Double-blind Placebo Parallel Controlled Clinical Trial. Zhao RH; Liu Y; Lu D; Wu Y; Wang XY; Li WL; Zeng C; Meng QW; Lian FM; Zhou J; Shi Y; Sun WW; Han Q; Tang Y; Shi G Chin J Integr Med; 2020 Feb; 26(2):92-99. PubMed ID: 31997236 [TBL] [Abstract][Full Text] [Related]
50. Effects of 15% Azelaic Acid Gel in the Management of Post-Inflammatory Erythema and Post-Inflammatory Hyperpigmentation in Acne Vulgaris. Shucheng H; Zhou X; Du D; Li J; Yu C; Jiang X Dermatol Ther (Heidelb); 2024 May; 14(5):1293-1314. PubMed ID: 38734843 [TBL] [Abstract][Full Text] [Related]
51. Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris in a preadolescent population. Eichenfield LF; Sugarman JL; Guenin E; Harris S; Bhatt V Pediatr Dermatol; 2019 Mar; 36(2):193-199. PubMed ID: 30656753 [TBL] [Abstract][Full Text] [Related]
52. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris. Tanghetti EA; Kircik LH; Green LJ; Guenin E; Harris S; Martin G; Pillai R J Drugs Dermatol; 2019 Jun; 18(6):542. PubMed ID: 31251546 [TBL] [Abstract][Full Text] [Related]
53. Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris. Eichenfield LF; Gold LS; Nahm WK; Cook-Bolden FE; Pariser DM J Drugs Dermatol; 2016 Dec; 15(12):1496-15027. PubMed ID: 28095573 [TBL] [Abstract][Full Text] [Related]
54. [Effects of Chinese medical facial mask comprehensive therapy in treating acne vulgaris]. Zeng X; Liu WL; Zhao T Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 May; 32(5):624-7. PubMed ID: 22679722 [TBL] [Abstract][Full Text] [Related]
55. Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials. Moore A; Green LJ; Bruce S; Sadick N; Tschen E; Werschler P; Cook-Bolden FE; Dhawan SS; Forsha D; Gold MH; Guenthner S; Kempers SE; Kircik LH; Parish JL; Rendon MI; Rich P; Stein-Gold L; Tyring SK; Weiss RA; Nasir A; Schmitz C; Boodhoo TI; Kaoukhov A; Berk DR J Drugs Dermatol; 2018 Sep; 17(9):987-996. PubMed ID: 30235387 [TBL] [Abstract][Full Text] [Related]
56. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides. Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175 [TBL] [Abstract][Full Text] [Related]
57. Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study. Leyden JJ; Sniukiene V; Berk DR; Kaoukhov A J Drugs Dermatol; 2018 Mar; 17(3):333-338. PubMed ID: 29537451 [TBL] [Abstract][Full Text] [Related]
58. [A multi-center randomized double-blinded, placebo-controlled clinical study on efficacy of composite sophora colon-soluble capsules in treating ulcerative colitis of internal dampness-heat accumulation syndrome type]. Tong ZQ; Yang B; Tong XY Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):172-6. PubMed ID: 21425568 [TBL] [Abstract][Full Text] [Related]
59. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population. Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791 [TBL] [Abstract][Full Text] [Related]
60. Efficacy of Modified Wuzhuyu Decoction Granule ( ) for Migraine Patients with Cold and Stasis Obstructing Meridian Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Liu HW; Zou YH; Cao KG; Yu LH; Zhang Y; Fu CH; Ma DY Chin J Integr Med; 2018 Jun; 24(6):409-414. PubMed ID: 28741060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]